Navigating the changing regulatory landscape
Regulations within the cell and gene therapy industry are constantly changing as scientific research and innovative approaches to product development are advancing rapidly. Lonza operates within a global market working with a wide variety of customers at all stages of product development from bench to bedside.
The cell and gene therapy regulatory affairs department are experts in keeping track of the ever-changing legislation in all regions where Lonza operates. We provide guidance to our customers worldwide and offer a broad range of RA capabilities to add value for new and existing customers during their product journey.